UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF THE
SECURITIES EXCHANGE ACT OF 1934
For the month of June, 2021
Commission File Number: 001-39446
CureVac N.V.
(Exact Name of Registrant as Specified in Its Charter)
Friedrich-Miescher-Strasse 15, 72076
Tübingen, Germany
+49 7071 9883 0
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
| Form 20-F | x | Form 40-F | ¨ |
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
| Yes | ¨ | No | x |
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
| Yes | ¨ | No | x |
On June 29, 2021, CureVac N.V. (the “Company”) issued a table containing tabulations of the votes cast at the Company’s annual general meeting.
The information in this Form 6-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| CUREVAC N.V. | |||
| By: | /s/ Franz-Werner Haas, LLD, LLM | ||
| Chief Executive Officer | |||
Date: June 29, 2021
EXHIBIT INDEX
| EXHIBIT NO. | DESCRIPTION | |
| 99.1 | CureVac N.V. Press Release dated June 29, 2021. |
Exhibit 99.1
CureVac N.V., Tübingen, Germany
Annual General Meeting of Shareholders, June 24, 2021
Voting results – Overview
| Agenda Item 3 | Adoption of the annual accounts over the financial year 2020 - accepted | |
|
139.848.106
|
Number of shares for which valid votes were cast (= 75.1 % of the registered share capital) | |
| 139.701.145 | Yes votes | 99.9 % of the valid votes cast |
| 5.162 | No votes | 0.0 % of the valid votes cast |
| Agenda Item 5 | Appointment of Mr. Antony Blanc as managing director - accepted | |
| 139.848.260 | Number of shares for which valid votes were cast (= 75.1 % of the registered share capital) | |
| 139.828.818 | Yes votes | 99.9 % of the valid votes cast |
| 10.469 | No votes | 0.0 % of the valid votes cast |
| Agenda Item 6 | Appointment of Mr. Klaus Edvardsen as managing director - accepted | |
| 139.848.106 | Number of shares for which valid votes were cast (= 75.1 % of the registered share capital) | |
| 139.828.984 | Yes votes | 99.9 % of the valid votes cast |
| 10.353 | No votes | 0.0 % of the valid votes cast |
| Agenda Item 7 | Re-appointment of Mr. Pierre Kemula as managing director - accepted | |
| 139.848.106 | Number of shares for which valid votes were cast (= 75.1 % of the registered share capital) | |
| 139.828.965 | Yes votes | 99.9 % of the valid votes cast |
| 10.093 | No votes | 0.0 % of the valid votes cast |
| Agenda Item 9 | Equity award to Mr. Jean Stéphenne as compensation for his services as supervisory director - accepted | |
| 139.848.106 | Number of shares for which valid votes were cast (= 75.1 % of the registered share capital) | |
| 109.114.552 | Yes votes | 78.0 % of the valid votes cast |
| 30.681.462 | No votes |
21.9 % of the valid votes cast |
| 1 |
CureVac N.V., Tübingen, Germany
Annual General Meeting of Shareholders, June 24, 2021
| Agenda Item 10 | Equity award to Mr. Ralf Clemens as compensation for his services as supervisory director – accepted | |
| 139.848.106 | Number of shares for which valid votes were cast (= 75.1 % of the registered share capital) | |
| 109.312.264 | Yes votes | 78.1 % of the valid votes cast |
| 30.483.567 | No votes | 21.8 % of the valid votes cast |
| Agenda Item 11 | Release of managing directors from liability for the exercise of their duties during the financial year 2020 - accepted | |
| 139.848.106 | Number of shares for which valid votes were cast (= 75.1 % of the registered share capital) | |
| 139.612.894 | Yes votes | 99.9 % of the valid votes cast |
| 86.005 | No votes | 0.0 % of the valid votes cast |
| Agenda Item 12 | Release of supervisory directors from liability for the exercise of their duties during the financial year 2020 - accepted | |
| 139.847.836 | Number of shares for which valid votes were cast (= 75.1 % of the registered share capital) | |
| 139.612.426 | Yes votes | 99.9 % of the valid votes cast |
| 88.620 | No votes | 0.0 % of the valid votes cast |
| Agenda Item 13 | Authorization of the management board to acquire shares (or depository receipts for shares) in the Company's capital – rejected | |
| 139.848.106 | Number of shares for which valid votes were cast (= 75.1 % of the registered share capital) | |
| 21.994.434 | Yes votes | 15.7 % of the valid votes cast |
| 117.824.940 | No votes | 84.2 % of the valid votes cast |
| Agenda Item 14 | Compensation of supervisory directors - accepted | |
| 139.847.806 | Number of shares for which valid votes were cast (= 75.1 % of the registered share capital) | |
| 109.934.665 | Yes votes | 78.6 % of the valid votes cast |
| 29.894.951 | No votes |
21.3 % of the valid votes cast |
| 2 |
CureVac N.V., Tübingen, Germany
Annual General Meeting of Shareholders, June 24, 2021
| Agenda Item 15 | Appointment of the external auditor for the financial year 2022 - accepted | |
| 139.848.106 | Number of shares for which valid votes were cast (= 75.1 % of the registered share capital) | |
| 139.833.679 | Yes votes | 99.9 % of the valid votes cast |
| 5.990 | No votes | 0.0 % of the valid votes cast |
| 3 |